WEGOVY 2 mg/mL
semaglutide · INJECTION, SOLUTION · Novo Nordisk Pharmaceutical Industries, LP
No Recall HistoryCurrently in Shortage
Plain English
WEGOVY is a injection, solution containing semaglutide at 2 mg/mL, taken subcutaneous. Manufactured by Novo Nordisk Pharmaceutical Industries, LP.
Key Facts
- Brand Name
- WEGOVY
- Generic Name
- semaglutide
- NDC Code (Product)
0169-1610- Manufacturer
- Novo Nordisk Pharmaceutical Industries, LP
- Strength
- 2 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA215256
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 06/05/2021
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
nausea2,654 reports
vomiting1,898 reports
diarrhoea1,279 reports
off label use1,157 reports
fatigue1,004 reports
constipation859 reports
headache783 reports
dizziness745 reports
weight increased742 reports
drug ineffective682 reports
Frequently Asked Questions
What is WEGOVY used for?
WEGOVY contains semaglutide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is WEGOVY a controlled substance?
WEGOVY is not classified as a controlled substance by the DEA.
What is the generic name for WEGOVY?
The generic name for WEGOVY is semaglutide. There are 4 other brand versions of semaglutide.
What is the NDC code for WEGOVY 2 mg/mL?
The NDC (National Drug Code) for WEGOVY 2 mg/mL is 0169-1610, listed by Novo Nordisk Pharmaceutical Industries, LP.